74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
H HEALIUS LTD
H
Closed
Sector Healthcare
1.3 -4.41
Overview
Share price change
24h
Min
1.28
Max
1.3
Income | -10M |
|---|---|
Sales | 247M 695M |
EPS | -0.004 |
Profit margin | -1.115 |
Employees | 4,329 |
EBITDA | -12M 176M |
Recommendations | Sell |
|---|---|
12 Months Forecast | -18.93 downside |
Next Dividend date | 11 Apr 2025 |
|---|---|
Next Ex Dividend date | 20 Mar 2025 |
Market Cap | -69M 980M |
|---|---|
Previous open | 5.71 |
Previous close | 1.3 |
News Sentiment
By Acuity
25%
75%
43 / 393 Healthcare
HEALIUS LTD Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
HEALIUS LTD Forecast
Price Target
By TipRanks
-18.93% downside
12 Months Forecast
Average 1.054 AUD -18.93%
High 1.1 AUD
Low 1.02 AUD
Based on 2 Wall Street analysts offering 12 month price targets forHEALIUS LTD - Dist in the last 3 months.
Sentiment
By Acuity
43 / 393 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About HEALIUS LTD
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
